Netherlands· NL-590577181a04
Bexsero, suspensie voor injectie in voorgevulde spuit
A meningokokkus b, multikomponenten-impfstoff product, registered in Netherlands by GSK Vaccines S.R.L.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Meningokokkus b, multikomponenten-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC J07AH09 (meningokokkus b, multikomponenten-impfstoff), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Meningokokkus b, multikomponenten-impfstoff · ATC J07AH09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Manufacturer
- GSK Vaccines S.R.L.
- Country
- Netherlands (NL)
- ATC code
- J07AH09
- ATC class
- Meningokokkus B, Multikomponenten-Impfstoff
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/12/812
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH09
Meningokokkus b, multikomponenten-impfstoff, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9245188-5259-4d82-afe8-fe43d6a466c6 GET /v1/drugs/a9245188-5259-4d82-afe8-fe43d6a466c6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspensie voor injectie",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/bexsero-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Meningococcus B, multicomponent vaccine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp109259",
"excipients": [
"ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
"HISTIDINE, (L-)",
"NATRIUMCHLORIDE",
"SACCHAROSE",
"WATER VOOR INJECTIE"
],
"substances": [
"GEINACTIVEERD BUITENMEMBRAAN BLAASJES EN FRAGMENTEN (OMV) VAN N. MENINGITIDIS, SEROGROEP B, Stam NZ98-254 GEMETEN ALS PorA, Serogroep P1.4 PROTEÏNE",
"RECOMBINANT N. MENINGITIDIS, SEROGROEP B NHBA (Neisseria Heparin Binding Antigen) PROTEÏNE, Stam NZ98-254 GEFUSEERD MET ACCESSORY PROTEÏNE 953, Stam 2996",
"RECOMBINANT N. MENINGITIDIS, SEROGROEP B NadA (Neisseria adhesin A) PROTEÏNE, Stam 2996",
"RECOMBINANT N. MENINGITIDIS, SEROGROUP B fHBP (factor H Binding Protein) PROTEÏNE, Stam MC58 GEFUSEERD MET ACCESSORY PROTEÏNE 936, Stam 2996"
],
"leaflet_url": null,
"authorised_at": "2013/01/14",
"procedure_number": "EMEA/H/C/002333",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/12/812",
"additional_monitoring": "N"
}See everything about meningokokkus b, multikomponenten-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.